Communication between acute myeloid leukemia (AML) and the bone marrow microenvironment is known to control disease progression. Therefore, regulation of AML cell trafficking and adhesion to the bone marrow is of significant interest. In this study, we demonstrate that differential expression of the membrane scaffold CD82 modulates the bone marrow homing of AML cells. By combining mutational analysis and super-resolution imaging, we identify membrane protein clustering by CD82 as a regulator of AML cell adhesion and bone marrow homing. Cluster analysis of super-resolution data indicates that N-linked glycosylation and palmitoylation of CD82 are both critical modifications that control the microdomain organization of CD82 as well as the nanoscale clustering of associated adhesion protein, N-cadherin. We demonstrate that the inhibition of CD82 glycosylation increases the molecular packing of N-cadherin and promotes the bone marrow homing of AML cells. In contrast, we find that the inhibition of CD82 palmitoylation disrupts the formation and organization of N-cadherin clusters and significantly diminishes bone marrow trafficking of AML. Taken together, these data establish a mechanism where the membrane organization of CD82, through specific posttranslational modifications, regulates N-cadherin clustering and membrane density, which impacts the in vivo trafficking of AML cells. As such, these observations provide an alternative model for targeting AML where modulation of protein organization within the membrane may be an effective treatment therapy to disrupt the bone marrow homing potential of AML cells.
INTRODUCTION
Acute myeloid leukemia (AML), the most common acute leukemia affecting adults, is characterized by an increase of immature myeloid blasts in the bone marrow that results from a loss of normal differentiation and proliferation of hematopoietic stem/progenitor cells (HSPCs). 1 Multiple subtypes of AML exist with a range of aggressiveness and treatment sensitivity. 2 One sign of disease aggressiveness is the ability of AML cells to home to the bone marrow and displace HSPCs. 3 Homing requires multiple steps including the ability to respond to a chemotactic gradient, extravasation and adhesion to specialized niches within the bone marrow. In fact, adhesion-mediated interactions between AML cells and the bone marrow have an important role in disease progression and chemoresistance. [4] [5] [6] [7] Therefore, identifying the molecules and mechanisms that mediate AML bone marrow adhesion and homing are fundamental to the development of future therapeutic treatments.
Recently, an AML protein profile was identified for a subpopulation of leukemic blasts, the leukemia stem cells (LSCs). This mass spectrometry study found an enrichment of specific adhesion-related proteins including CD44, integrin α6, CD47 and CD82 on LSCs. 8 An alternative AML screen also identified the upregulation of CD82 in LSCs where it was suggested to modulate AML adhesion to the bone marrow. 9 Following its initial cloning, [10] [11] [12] the tetraspanin CD82 (or Kai1) was described as a metastasis suppressor in solid tumors. 13 Tetraspanins are evolutionarily conserved membrane proteins present in most eukaryotes that function as mediators of cell adhesion, trafficking and cell signaling. 14 Through their ability to associate in cis with other tetraspanins, cell adhesion molecules and signaling receptors, tetraspanins form tetraspanin-enriched microdomains. 15, 16 Formation of tetraspanin-enriched microdomains enables tetraspanins to serve as molecular organizers for membrane proteins. 15 Our recent work identified a role for CD82 in the homing of human HSPCs, which we linked to the membrane organization of CD82 and associated adhesion and signaling molecules. 17 Currently, basic questions concerning the formation and regulation of tetraspanin-enriched microdomains and their modulation of adhesion receptors, which specifically impact bone marrow homing, still remain.
N-cadherin is a classical cadherin that interacts homophilically with cadherins on neighboring cells to form adherence junctions, which mechanically link cells and relay signaling information from the extracellular environment. 18, 19 Although the function of N-cadherin remains controversial for HSPCs, [20] [21] [22] its role in the regulation of specific leukemias is more evident. In AML, the LSC compartment that expresses N-cadherin is relatively resistant to chemotherapy treatments and highly enriched following chemotherapy. 23 Subsequent studies suggest that N-cadherin expression facilitates LSCs to initiate and induce AML development. 24 In combination, these data indicate that N-cadherin participates in the protection of LSCs and the relapse of AML; therefore, the regulation of N-cadherin function in AML is of significant interest.
The dynamic regulation of cadherin-mediated adhesiveness is thought to involve modulation of cadherin density arrangement on the cell surface. 25 Moreover, clustering of cell surface cadherins is known to modify cadherin-mediated adhesion and signal transduction, but the mechanism of cadherin clustering is poorly understood. 26 Combining super-resolution imaging, CD82 mutational analysis and in vivo functional studies, we utilize a multiscale approach that identifies CD82 as a regulator of AML cell adhesion and bone marrow homing. Our work establishes a mechanism where the membrane organization of CD82, which is dependent upon specific posttranslational modifications, regulates N-cadherin clustering and membrane density. We demonstrate that the spatial regulation of N-cadherin by CD82 leads to functional in vivo consequences for AML cell behavior.
RESULTS AND DISCUSSION
CD82 expression increases AML cell homing to the bone marrow and modulates N-cadherin-mediated adhesion To gain mechanistic insight into how CD82 affects bone marrow homing, we used the previously described control, CD82 overexpression (CD82OE) and CD82 knockdown (CD82KD) human KG1a cells (Figure 1a ) 27 to monitor the changes in AML cell homing using NSG mice. Sixteen hours following injection, we detected no difference in AML cell localization to the spleen or blood (Figure 1b) . However, when we analyzed the bone marrow, we identified a marked reduction in bone marrow homing of the CD82KD cells along with a modest increase in the bone marrow homing of CD82OE cells when compared with control cells. Therefore, CD82 expression can modify the in vivo trafficking of AML cells. To further evaluate this finding, we compared the homing capacity of primary human AML cells with differential CD82 expression (Figures 1c and e) . Consistent with the cell line data, we find that AML cells with higher CD82 expression display improved bone marrow homing when compared with AML cells with lower expression of CD82 (Figures 1d and f) . The combined cell line and primary AML cell data suggest that CD82 expression modulates AML cell homing to the bone marrow microenvironment, which is an indicator of aggressive AML.
Bone marrow homing of AML cells requires a series of complex steps involving a combination of cell migration and adhesion signaling. The chemokine receptor, CXCR4, with its ligand, stromal derived factor-1 (SDF-1), is the major receptor signaling pathway used for bone marrow homing by HSPCs 28 and various types of leukemic cells. 29 Although functional interactions between tetraspanins and CXCR4 signaling were shown previously, 30 we did not detect any CXCR4 expression differences between the control, CD82OE and CD82KD cells (Supplementary Figures 1a and b) . Additional analysis of cell migration toward SDF-1 illustrates no difference in the migratory behavior of these cells in a transwell assay (data not shown). Therefore, these data suggest that the observed changes in bone marrow homing are not likely due to CD82-mediated effects on the CXCR4 homing signal.
Next, we turned to evaluate whether CD82 expression may affect AML cell adhesion within the bone marrow by screening the cell lines for expression changes in the cadherin family of cell-cell adhesion molecules. 18, 19 While we were unable to detect differences in the expression of E-cadherin and P-cadherin ( Supplementary Figures 1c and d) , the surface expression of N-cadherin was significantly reduced in the CD82KD cells ( Figure 1g) . Recently, N-cadherin enrichment was identified on the surface of LSCs, which was proposed to enable the cell adhesion of AML cells to the bone marrow. 23, 24 Therefore, we used a fluorescence-based adhesion assay to measure changes in cell adhesion to osteoblasts and purified N-cadherin. Consistent with the homing experiments, we find that CD82KD results in a decrease in cell adhesion to osteoblastic cells as well as purified N-cadherin, whereas CD82OE cells display an increase in cell adhesion (Figures 1h and i) . Furthermore, the reintroduction of CD82 back into the CD82KD cells recovered the reduced adhesion phenotype (Figures 1j and k) . Together, these data implicate a specific role for N-cadherin in CD82-mediated AML cell adhesion.
CD82 membrane clustering is altered by glycosylation and palmitoylation status A distinct feature of tetraspanins is their ability to associate with other tetraspanins, cell adhesion molecules and signaling receptors, thereby serving as molecular facilitators for membrane proteins. 15, 16 Therefore, the mechanism by which CD82 regulates AML cell adhesion and homing is likely to be dependent upon its ability to form higher order protein complexes in the cell membrane. Moreover, the regulation of tetraspanin-enriched microdomain formation and stability is of significant interest. Previously, our group and others showed that the palmitoylation of the membrane proximal cysteines of CD82 promotes the oligomerization and dynamic reorganization of proteins into microdomains. 27, [31] [32] [33] Furthermore, cell surface glycosylation, which can alter protein-protein interactions, also regulates the membrane organization of proteins. The glycosylation of membrane-bound proteins is perturbed in many cancers and can be regulated by oncogenic factors. [34] [35] [36] Recently, the membrane glycosylation of CD82 was shown to have a role in cell adhesion and motility in specific cancers. 37, 38 To evaluate how palmitoylation and glycosylation of CD82 affect its membrane organization and the aggressive potential of AML, two constructs were generated where: (i) the membrane proximal cysteines were mutated to serine, preventing palmitoylation (Palm-CD82), 27, 39 and (ii) the three N-linked glycosylation sites were mutated to glutamine, inhibiting glycosylation (Ngly-CD82) ( Figure 2a ). These constructs were stably transfected into KG1a cells and Figure 2b indicates that the Ngly-CD82 and Palm-CD82 cells express similar CD82 surface levels as the CD82OE cells. Interestingly, both mutants contain intracellular CD82, which may further suggest changes in CD82 protein trafficking that are regulated by these posttranslational modifications.
Next, we assessed how these CD82 mutations affect the membrane organization of the CD82 scaffold. To measure differences in microdomain organization between control, CD82OE, Ngly-CD82 and Palm-CD82 cells, we used the superresolution imaging technique, direct stochastic optical reconstruction microscopy (dSTORM). 40 Super-resolution imaging allows us to quantify the changes in CD82 membrane organization at the level of individual molecules on the nanometer scale (Figures 2c-f) . Initially, the reconstructed dSTORM images were analyzed using the Hopkins index, which determines the extent to which CD82 is present in a random distribution on the cell surface. 41, 42 Consistent with our visual observations, we find that each of the CD82-expressing AML cells has a Hopkins index that is significantly higher than what would be expected for a random distribution of molecules (0.5), demonstrating that CD82 is not randomly distributed, but organized into membrane clusters (Figure 2g) .
The CD82 dSTORM images were also analyzed using the density-based spatial clustering of applications with noise clustering algorithm (DBSCAN) (Figures 2c-f , zoom) as previously described. 43 From these measurements, we determined that CD82OE cells have an increased CD82 cluster diameter and area with respect to control cells, which is likely due to the increased expression of CD82 (Figures 2h and i) . Interestingly, the CD82 cluster size quantified for both the Ngly-CD82 and Palm-CD82 cells indicates an even further increase in CD82 cluster diameter and area when compared with CD82OE cells (Figures 2h and i) . Measurements of the Palm-CD82 cells detect the most significant increase in CD82 cluster size and decrease in CD82 cluster organization, which is consistent with previous work demonstrating the importance of the palmitoylation sites in the lateral packing of CD82. 27, 33 Previous work from our lab identified smaller CD82 cluster sizes in the Palm-CD82 cells using pair-auto correlation function analysis, which is an averaged radial cluster measurement. In contrast, the DBSCAN algorithm enables the quantification of larger scale clusters of varying shapes and sizes, which is what we find for CD82. As for the N-glycosylation mutation, the effects on CD82 cluster size are more modest, however, we do detect an increase in CD82 cluster diameter and area. We also imaged and analyzed the CD82 cluster area and diameter in primary AML cells. Consistent with the cell line data, Figures 2j-l further illustrate the differentiation clustering of CD82 in primary patient samples. In combination, these data illustrate that while the CD82OE, Ngly-CD82 and Palm-CD82 cells all have similar CD82 surface expression, the Ngly-and Palm-mutations change the CD82 membrane distribution into larger ordered CD82 clusters. Therefore, these specific posttranslational modifications regulate the membrane organization of CD82, which may in turn modulate protein-protein interactions important for bone marrow homing and adhesion.
N-cadherin clustering is regulated by CD82 membrane organization Next, we set out to determine whether the described changes in CD82 membrane organization affect the expression and distribution of N-cadherin. First, we confirmed that N-cadherin surface expression is consistent between the CD82OE, Ngly-CD82 and Palm-CD82 cell lines (Figure 3a) . Next, we performed confocal immunofluorescence imaging to analyze N-cadherin distribution in the cells. Figure 3b illustrates that both CD82 and N-cadherin are localized to the plasma membrane in each of the cells except for the CD82KD cells, which have reduced expression levels of CD82 and a punctate distribution of N-cadherin. In addition to the change in N-cadherin distribution upon CD82KD, a reduction in N-cadherin expression is observed, which is consistent with the flow cytometry data (Figure 1g ). Moreover, double staining of primary AML cells suggests a similar surface expression profile for CD82 and N-cadherin (Figure 3c ). To further assess potential protein-protein interactions between CD82 and N-cadherin, we completed co-immunoprecipitation experiments using Brij lystates. The ability of CD82 to pull down N-cadherin in this mild detergent (Figure 3d ) suggests that CD82 and N-cadherin are present in a protein complex. Surface clustering of N-cadherin can trigger signaling events, which promote cell adhesion. 25 Furthermore, the regulatory mechanism of cadherin clustering is a critical aspect of cadherin adhesion because the adhesive capacity of individual cadherins is negligible. 26 Therefore, the lateral association between cadherin receptors is a prerequisite for the formation of adhesive dimers. 44 To quantify how changes in CD82 membrane organization affect the nanoscale organization of N-cadherin, we again used dSTORM (Figures 4a-d) . Analysis of the N-cadherin dSTORM images with the DBSCAN algorithm (Figures 4e-h ) suggests that N-cadherin cluster size and diameter is significantly decreased in Ngly-CD82 and Palm-CD82 cells when compared with control and CD82OE cells (Figures 4i and j) . More importantly, Palm-CD82 cells display a marked decrease in the number of N-cadherin clusters when compared with CD82OE or control cells (Figure 4k ). Additional analysis of Palm-CD82 cells also identified that the majority of the N-cadherin molecules are distributed diffusely throughout the membrane and not localized to organized clusters (Figure 4l) . Thus, the palmitoylation of CD82 and its lateral assembly significantly affects the formation of N-cadherin adhesive protein complexes. Interestingly, we also find that the Ngly-CD82 cells demonstrate a significant increase in the density or molecular confinement of N-cadherin molecules into a cluster (Figure 4m) , which is predicted to modulate N-cadherin function. We find that N-glycosylation of CD82 maintains N-cadherin clusters at approximately 80 nm. However, when the N-linked glycosylation sites on CD82 are mutated, the average size of N-cadherin clusters shrinks to approximately 65 nm, which leads to an increase in the molecular confinement of N-cadherin in each cluster. Together, these data suggest that whereas palmitoylation of CD82 regulates N-cadherin assembly into clusters, N-glycosylation of CD82 affects the nanoscale packing of N-cadherin. Therefore, in addition to N-cadherin expression, the regulation of N-cadherin membrane organization by CD82 may also be an important regulatory mechanism for controlling N-cadherin function and subsequent behavior of AML.
Molecular scale organization of CD82 alters the bone marrow homing capacity of AML cells The lateral assembly of cadherins in the membrane can stimulate signaling events and promote cell adhesion. 25 Therefore, we assessed whether the CD82-mediated changes in N-cadherin clustering affect the homing of AML cells into the bone marrow. We injected the Ngly-CD82, Palm-CD82 and control cells into NSG mice to measure potential differences in bone marrow homing. Interestingly, we detected a significant increase in the ability of the Ngly-CD82 cells to home to the bone marrow when compared with control cells, whereas the Palm-CD82 cells display a substantial decrease in bone marrow homing (Figures 4n and o) . Analysis of the blood and spleen for Ngly-CD82 and Palm-CD82 cell localization identified no differences. To assess the role of N-cadherin in the enhanced homing of the Ngly-CD82 cells, we pretreated the cells with the N-cadherin blocking antibody (GC-4) prior to injection. Figure 4p shows a disruption in Ngly-CD82 cell homing when N-cadherin is inhibited. Together these data demonstrate that CD82 and its posttranslational modifications Figure 1 . CD82 expression regulates homing to the bone marrow and adhesion to niche components. (a) Flow cytometry analysis of CD82 surface expression using previously described CD82OE, CD82KD and control KG1a cell lines 27 (ATCC, Manassas, VA, USA; CCL-246.1). Cells were characterized using Alexa Fluor 647 anti-human CD82 (clone ASL-24, BioLegend, San Diego, CA, USA). Data were acquired using an Accuri flow cytometer C6 (BD Bioscience, San Jose, CA, USA) and analyzed with FlowJo X software (Tree Star, Inc., Ashland, OR, USA). (b) Bone marrow homing of CD82OE, KD or Ctrl KG1a cells. Cells were labeled with carboxyfluorescein succinimidyl ester (CFSE) according to the manufacturer's protocol. After labeling, 1 × 10 6 cells were injected intravenous into female NOD. Cg-Prkdc scid Il2rg tm1wjl /SzJ (NSG) mice 8-12 weeks of age. NSG mice were housed and bred at the Animal Research Facility under specific pathogen-free conditions at the University of New Mexico Health Sciences Center (Albuquerque, NM, USA). All procedures were approved by the University of New Mexico Institutional Animal Care and Use Committee and carried out in accordance with the NIH Guide for the Care and Use of Laboratory Animals. Sixteen hours after injection, the blood, spleen and bone marrow were harvested. A single cell suspension was generated and red blood cells were lysed with ACKs buffer (15 M NH4Cl, 10 mM KHCO3, 0.1 mM EDTA). Cells were treated with Fc block, and then stained for human-CD45 and analyzed by flow cytometry for CFSE and huCD45 (Clone HI30, BioLegend) double positive cells. Percent input was calculated on the basis of the number of double positive events multiplied by total tissue cell number divided by the number of cells injected all multiplied by 100 (n = 5 mice). (c and e) Flow cytometry analysis of CD82 on the surface of primary AML cells. (d and f) Tissue harvest from 8-to 10-week-old male and female NSG mice 16 h after intravenous injection of CFSE-labeled primary AML cells (1 × 10 6 cells) using the protocol described above (n = 5 mice/patient sample). AML patient samples were deidentified and obtained from the UNM Health Science center (HSC) cell bank. Flow cytometry analysis of (g) N-cadherin (Clone 8C11, BioLegend) surface expression on Ctrl, CD82KD or CD82OE KG1a cells. Fluorescence-based cell adhesion assay using Ctrl, CD82KD and CD82OE cells. Cells were labeled with 2 μM calcein (Invitrogen, Carlsbad, CA, USA) and allowed to adhere to (h) SaOS-2 osteoblastic cells (ATCC) or (i) purified N-cadherin (R&D Systems, Minneapolis, MN, USA) for 1 h. Non-adherent cells were removed by washing and remaining fluorescent cells were measured by using synergyH1 plate reader (Biotek, Winooski, VT, USA) and analyzed with the Gen5 2.00.18 plate reader software (n = 3 replicates). (j) Flow cytometry analysis for CD82 following the nucleofection of mCherry or the mCherry-CD82 vectors into the CD82KD cells. (k) Osteoblastic cell adhesion analysis (as previously described) for CD82KD cells upon CD82 reintroduction. For all graphs, mean is displayed with error bars denoting s.d., all variances were determined to be similar; no randomization or blinding methods were used; statistics were performed using two-sided unpaired t-test. (*P o0.05, **P o0.01, ***P o0.001). 27 three N-linked glycosylation sites on CD82, Asparagine 129, 157 and 198 were mutated individually to glutamine using a QuickChange II site-directed mutagenesis kit (Agilent, Santa Clara, CA, USA) according to the manufacturer's instructions (Ngly-CD82). All mutations were confirmed by DNA sequence analysis (ACGT Inc., Wheeling, IL, USA). CD82 palmitoylation mutant was generated as previously described (Palm-CD82). 27 (b) Flow cytometry analysis of CD82 surface expression on CD82OE, Ngly-CD82 and Palm-CD82 cells (clone ASL-24, BioLegend). (c-f) Reconstructed dSTORM images of CD82 distribution on each cell line. The previously described labeling, imaging and fitting protocols were followed. 27, 48 (g) Hopkins analysis of CD82 cellular membrane organization on ctrl (n = 8), CD82OE (n = 11), Palm-CD82 (n = 13) and Ngly-CD82 (n = 12 cells) using reconstructed dSTORM images was performed using SuperCluster Matlab software from the UNM Spatiotemporal Modeling Center. (Code availability: http://stmc.health.unm. edu/tools-and-data/index.html). The reconstructed dSTORM images were also analyzed with the DBSCAN algorithm to generate DBSCAN images (c-f zooms), which represent clustered CD82 localizations in color and non-clustered CD82 localizations in gray. A 6 × 6-μm box was examined for clustering using an epsilon value of 100 nm and an n value of 10 localizations. Quantification of (h) CD82 cluster diameter and (i) CD82 cluster area based on DBSCAN analysis (ctrl n = 3 cells n = 315 clusters, CD82OE n = 4 cells n = 711 clusters, Ngly-CD82 n = 5 cells n = 772 clusters and Palm-CD82 n = 3 cells n = 356 clusters). (j-l) dSTORM imaging and DBSCAN analysis for CD82 cluster area and diameter was performed on four primary AML samples (P1 n = 4 cells n = 130 clusters, P2 n = 3 cells n = 74 clusters, P3 n = 3 cells n = 75 clusters, P4 n = 3 cells n = 84 clusters). The mean is displayed with s.e.m.; statistics were performed using one-way analysis of variance, post hoc two-sided unpaired ttest with Welch's correction for groups with unequal standard deviations. (**Po0.01, ***Po 0.001, ****Po 0.0001).
regulate N-cadherin cluster size, organization and density, which modulate AML bone marrow homing.
Although protein expression has a critical role in AML, 45 our study suggests that protein organization can be equally important. We define a pathway by which CD82 regulates bone marrow homing of AML cells through the membrane clustering of N-cadherin (Figure 4q) . Establishment of AML within the bone marrow has extremely poor patient outcomes and we speculate that N-cadherin clustering may serve as a valuable marker to predict the aggressive behavior of AML. In addition, these findings provide an alternative model for targeting AML where modulation of protein organization within the membrane may be an effective treatment to dislodge AML cells from the protective environment of the bone marrow. Although N-cadherin is a focus of this study, we propose that N-cadherin will most likely model other adhesive proteins expressed on the cell surface such as selectins and integrins. In fact, CD82 regulation of specific integrin organization has been previously described in a variety of cellular systems. 27, 46, 47 In summary, these observations strengthen the significance of tetraspanin-mediated membrane organization within a complex multistep process such as bone marrow homing. Moreover, we reason that CD82 serves as to regulate cellular behavior by modulating the topological distribution of protein networks on the cell membrane. It is plausible that this regulation ultimately leads to more robust signaling and adhesive potential that can be harnessed in disease states such as AML where cancer stem cells have a greater fitness advantage over normal HSPCs. Together, these data suggest that membrane clustering of proteins can regulate the aggressive potential of AML cells and may serve as a novel therapeutic target for future disease treatments.
